Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.

IL-4 antagonist to improve moderate-severe atopic dermatitis

OCT is a noninvasive imaging device that can be used to monitor inflammatory skin disorders.

RCM is a noninvasive imaging device, with resolution approaching that of histology, which can monitor structural changes in the epidermis and superficial dermis, monitor inflammatory cells, and can overcome the limitations of a traditional biopsy.